NasdaqGS - Nasdaq Real Time Price
USD
The Cooper Companies, Inc. (COO)
65.91
+0.86
(+1.32%)
As of June 18 at 4:00:01 PM EDT. Market Open.
Trade COO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for COO
- Previous Close
65.05 - Open
65.00 - Bid 60.31 x 200
- Ask 71.01 x 200
- Day's Range
65.00 - 66.23 - 52 Week Range
58.89 - 89.83 - Volume
3,523,050 - Avg. Volume
2,624,069 - Market Cap (intraday)
12.854B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
55.86 - EPS (TTM)
1.18 - Earnings Date (est.) Sep 3, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 26, 2023
- 1y Target Est
80.57
Recent News
View More
Performance Overview
Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
COO
19.58%
S&P 500 (^GSPC)
9.57%
1-Year Return
COO
5.59%
S&P 500 (^GSPC)
25.41%
3-Year Return
COO
28.24%
S&P 500 (^GSPC)
70.10%
5-Year Return
COO
31.31%
S&P 500 (^GSPC)
80.02%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/18/2026
-
Market Cap
12.85B
-
Enterprise Value
15.18B
-
Trailing P/E
55.86
-
Forward P/E
14.10
-
PEG Ratio (5yr expected)
0.66
-
Price/Sales (ttm)
3.08
-
Price/Book (mrq)
1.56
-
Enterprise Value/Revenue
3.59
-
Enterprise Value/EBITDA
17.05
Financial Highlights
Profitability and Income Statement
-
Profit Margin
5.57%
-
Return on Assets (ttm)
2.52%
-
Return on Equity (ttm)
2.85%
-
Revenue (ttm)
4.23B
-
Net Income Avi to Common (ttm)
235.8M
-
Diluted EPS (ttm)
1.18
Balance Sheet and Cash Flow
-
Total Cash (mrq)
138.8M
-
Total Debt/Equity (mrq)
33.09%
-
Levered Free Cash Flow (ttm)
424.28M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
327.95
+1.35%
Mkt Cap
23.169B
Industry
Medical Instruments & Supplies
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Lowering target price to $64.00
COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $64.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice Target -
Raising target price to $65.00
COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $65.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice Target -
Cooper Earnings: Asia Remains Weak, but All Wheels Elsewhere Are Turning in the Right Direction
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice Target -
Lowering target price to $57.00
COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $57.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target
